➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Colorcon
Dow
Johnson and Johnson
Boehringer Ingelheim

Last Updated: August 13, 2020

DrugPatentWatch Database Preview

MIDOL LIQUID GELS Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Midol Liquid Gels patents expire, and what generic alternatives are available?

Midol Liquid Gels is a drug marketed by Bionpharma Inc and is included in one NDA.

The generic ingredient in MIDOL LIQUID GELS is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and twenty-one suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.

US ANDA Litigation and Generic Entry Outlook for Midol Liquid Gels

A generic version of MIDOL LIQUID GELS was approved as ibuprofen by OHM on July 15th, 1986.

  Start Trial

Summary for MIDOL LIQUID GELS
Drug patent expirations by year for MIDOL LIQUID GELS
Recent Clinical Trials for MIDOL LIQUID GELS

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
German Consortium for Translational Cancer ResearchPhase 2
German Cancer Research CenterPhase 2
Baylor College of MedicinePhase 3

See all MIDOL LIQUID GELS clinical trials

US Patents and Regulatory Information for MIDOL LIQUID GELS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bionpharma Inc MIDOL LIQUID GELS ibuprofen CAPSULE;ORAL 021472-001 Oct 18, 2002 OTC Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
Colorcon
Boehringer Ingelheim
Express Scripts
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.